Detailed price information for Cue Biopharma Inc (CUE-Q) from The Globe and Mail including charting and trades.
Oct 13 (Reuters) - The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback